Clinical Assistant Professor, Anesthesiology, Perioperative and Pain Medicine
Honors & Awards
Kelley M. Skeff GME Professionalism Award - Nominee, Stanford School of Medicine (2021)
John P. McGovern Academy of Oslerian Medicine - Thayer Award for Excellence in Teaching, University of Texas Medical Branch (2019)
GME Quality Improvement & Patient Safety Poster Session - 2nd place, University of Texas Medical Branch (2019)
Charles R. Allen Resident of the Year, University of Texas Medical Branch (2019)
Marvin S. Cohen Award for Excellence in Pediatric Anesthesia, University of Texas Medical Branch (2019)
Chief Anesthesia Resident, University of Texas Medical Branch (2019)
Alfred Soffer Rearch Award - CHEST 2011 Scientific Abstract and Case Report Award Winner, International American College of Chest Physicians (2011)
Fellowship, Stanford School of Medicine - Pediatric Pain Medicine, CA (2021)
Fellowship: Stanford University Pediatric Anesthesia Fellowship (2020) CA
Residency: University of Texas Medical Branch Anesthesiology Residency (2019) TX
Internship: University of Texas Medical Branch (2016) TX
Medical Education: Texas Tech University Health Sciences Center School of Medicine (2015) TX
- Analgesic Drug Development for Children: A History of Shortcomings Until Now. Journal of pain research 2021; 14: 867–70
The virtual visit: Using immersive technology to visit hospitals during social distancing and beyond.
2020; 30 (8): 954–56
Medical trainees face substantial financial and scheduling burdens during the interview process at various levels of training. With current social distancing and travel restrictions in place, in-person interviews now carry an additional health risk that make it difficult for training programs and applicants to conduct a thorough interview process. Virtual interviews and presentations are some of the technology-driven solutions that have been accelerated in the current social context to mitigate financial burdens and health risks. By utilizing immersive technology to provide virtual tours of training sites, applicants have the opportunity to gain a comprehensive perspective before making the critical decision of where to continue their training. We provide our experiences with creating a 360-degree virtual tour of our children's hospital and the methods for distribution to pediatric anesthesia fellowship applicants. Moving forward, training programs may consider immersive virtual tours as an alternative to face-to-face site visits to not only help alleviate the financial and scheduling burden for applicants but also to protect the well-being of healthcare personnel and patients in the context of a global pandemic.
View details for DOI 10.1111/pan.13922
View details for PubMedID 32959974
Low-, medium- and high-dose steroids with or without aminocaproic acid in adult hematopoietic SCT patients with diffuse alveolar hemorrhage.
Bone marrow transplantation
2015; 50 (3): 420-6
Diffuse alveolar hemorrhage (DAH) is a poorly understood complication of transplantation carrying a high mortality. Patients commonly deteriorate and require intensive care unit (ICU) admission. Treatment with high-dose steroids and aminocaproic acid (ACA) has been suggested. The current study examined 119 critically ill adult hematopoietic transplant patients treated for DAH. Patients were subdivided into low-, medium- and high-dose steroid groups with or without ACA. All groups had similar baseline characteristics and severity of illness scores. Primary objectives were 30, 60, 100 day, ICU and hospital mortality. Overall mortality (n=119) on day 100 was high at 85%. In the steroids and ACA cohort (n=82), there were no significant differences in 30, 60, 100, day, ICU and hospital mortality between the dosing groups. In the steroids only cohort (n=37), the low-dose steroid group had a lower ICU and hospital mortality (P=0.02). Adjunctive treatment with ACA did not produce differences in outcomes. In the multivariate analysis, medium- and high-dose steroids were associated with a higher ICU mortality (P=0.01) as compared with the low-dose group. Our data suggest that treatment strategies may need to be reanalyzed to avoid potentially unnecessary and potentially harmful therapies.
View details for DOI 10.1038/bmt.2014.287
View details for PubMedID 25531284
MASS OF LUMINAL SECRETION: COMPARISON BETWEEN PNEUX AND PVC TRACHEAL TUBES
LIPPINCOTT WILLIAMS & WILKINS. 2012: U285
View details for Web of Science ID 000312045701318
Thrombocytopenia Does Not Protect From Deep Vein Thrombosis in Critically Ill Cancer Patients
2011; 140 (4)
View details for DOI 10.1378/chest.1119773